Companies: 49,246 Total Market Cap: 132386205533959.40

Haleon Pakistan Limited

PSX-HALEON
Pharmaceutical Preparations
Rank #17194
Market Cap 297.68 M
Volume 74,578
Price 2.54
Change (%) 0.99%
Country or region Pakistan Pakistan

Haleon Pakistan Limited's latest marketcap:

297.68 M

As of 05/20/2025, Haleon Pakistan Limited's market capitalization has reached $297.68 M. According to our data, Haleon Pakistan Limited is the 17194th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 297.68 M
Revenue (ttm) 137.41 M
Net Income (ttm) 18.46 M
Shares Out 117.05 M
EPS (ttm) 0.16
Forward PE 0.00
Ex-Dividend Date 03/11/2025
Earnings Date 04/25/2025
Market Cap Chart
Data Updated: 05/20/2025

Haleon Pakistan Limited's yearly market capitalization.

Haleon Pakistan Limited has seen its market value grow from rs31.03 B to rs85.10 B since 2020, representing a total increase of 174.21% and an annual compound growth rate (CAGR) of 25.86%.
Date Market Cap Change (%)
05/20/2025 rs85.10 B -14.15%
12/31/2024 rs94.54 B 377.88%
12/29/2023 rs19.78 B 3.12%
12/30/2022 rs19.19 B -32.01%
12/31/2021 rs28.22 B -9.08%
12/31/2020 rs31.03 B

Company Profile

About Haleon Pakistan Limited

Haleon Pakistan Limited is a leading manufacturer and marketer of consumer healthcare products, operating in Pakistan and exporting to multiple regions worldwide, including Africa, Australia, North America, Asia, the Middle East, and Europe.

Product Portfolio

The company specializes in a diverse range of healthcare products, including:

  • Oral health (Sensodyne, paradontax)
  • Pain relief (Panadol, Voltral Emulgel)
  • Vitamins & mineral supplements (CaC-1000 Plus, Qalsium-D)
  • Respiratory health (ENO, Hydrozole)

Key Brands

Haleon Pakistan's products are sold under well-known brands such as:

  • Panadol
  • Sensodyne
  • ENO
  • Voltral Emulgel
  • T-Day

Global Reach

The company exports its products to key international markets, including the Philippines, Vietnam, and the East West Africa region.

Corporate Background

Originally established as GlaxoSmithKline Consumer Healthcare Pakistan Limited, the company rebranded to Haleon Pakistan Limited in January 2023. Incorporated in 2015 and headquartered in Karachi, Pakistan, it operates as a subsidiary of Glaxosmithkline Consumer Healthcare B.V.

Frequently Asked Questions

As of 05/20/2025, Haleon Pakistan Limited (including the parent company, if applicable) has an estimated market capitalization of $297.68 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Haleon Pakistan Limited global market capitalization ranking is approximately 17194 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Pakistan
Founded 2015
IPO Date n/a
Employees 450
CEO Farhan Haroon
Sector
Industry Pharmaceutical Preparations
Address 11-A, Sky Tower (East Wing)
Karachi, 75600
Pakistan
Website https://www.haleon.pk
People Also Watch
Ipsen S.A.
138.21 0.99%
Krka, d. d.
209.75 0.99%
BUD-RICHTER
29.11 0.99%
Hugel
244.93 0.99%